MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -66.7% | 2,000 | 0.0% | 0.00% | -75.0% |
| Q1 2017 | $6,000 | -25.0% | 2,000 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $8,000 | -38.5% | 2,000 | 0.0% | 0.01% | -44.4% |
| Q3 2016 | $13,000 | +18.2% | 2,000 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $11,000 | -35.3% | 2,000 | 0.0% | 0.01% | -38.5% |
| Q1 2016 | $17,000 | +6.2% | 2,000 | 0.0% | 0.01% | +8.3% |
| Q4 2015 | $16,000 | -52.9% | 2,000 | -50.0% | 0.01% | -55.6% |
| Q3 2015 | $34,000 | -30.6% | 4,000 | 0.0% | 0.03% | -22.9% |
| Q2 2015 | $49,000 | +2.1% | 4,000 | 0.0% | 0.04% | +6.1% |
| Q1 2015 | $48,000 | +6.7% | 4,000 | 0.0% | 0.03% | 0.0% |
| Q4 2014 | $45,000 | – | 4,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |